Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

trial

Fatherland admitted to conspiracy for’daughter entrance exams’, own trial also became disadvantageous

Fatherland admitted to conspiracy for’daughter entrance exams’, own trial also became disadvantageous

[사회]Yoon Seok-yeol Today’s additional interrogation…”The actual main case trial”

[사회]Yoon Seok-yeol Today’s additional interrogation…”The actual main case trial”

Even without Yoon Seok-yeol…  Three civil servants passed the trial for’removing nuclear data’

Even without Yoon Seok-yeol… Three civil servants passed the trial for’removing nuclear data’

Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”

Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”

Daewoong Pharmaceutical confirms the treatment effect of COVID-19 in Hoystar tablet ‘2a clinical trial’

Daewoong Pharmaceutical confirms the treatment effect of COVID-19 in Hoystar tablet ‘2a clinical trial’

‘College Examination/Private Fund Corruption’ Kyung-Shim Jung, 4 years imprisonment for the first trial, a fine of 500 million (2)

‘College Examination/Private Fund Corruption’ Kyung-Shim Jung, 4 years imprisonment for the first trial, a fine of 500 million (2)

Daewoong Pharmaceutical confirms the effect of Hoystar tablet COVID-19 treatment in Phase 2a clinical trial

Daewoong Pharmaceutical confirms the effect of Hoystar tablet COVID-19 treatment in Phase 2a clinical trial

Daewoong Pharmaceutical’s’Hoystar tablet’ confirmed the possibility of COVID-19 treatment in phase 2a clinical trial

Daewoong Pharmaceutical’s’Hoystar tablet’ confirmed the possibility of COVID-19 treatment in phase 2a clinical trial

Newer posts
← Previous Page1 … Page18 Page19

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en